|
2024
|
Invention
|
Compounds and methods for skipping exon 50 in duchenne muscular dystrophy. DMD DMD gene, wherein ... |
|
|
Invention
|
Cyclic peptides for delivering therapeutics. Compounds are provided that comprise an endosomal es... |
|
|
Invention
|
Intracellular targeting of oligonucleotides. Compounds are provided include a. cyclic cell penetr... |
|
|
Invention
|
Cell penetrating peptides and methods of making and using thereof.
Disclosed herein are compound... |
|
|
Invention
|
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy.
Disclo... |
|
2023
|
Invention
|
Antisense compounds and methods for targeting cug repeats.
Compounds comprising a cyclic peptide... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of inflammato... |
|
|
P/S
|
Providing grants to organizations dedicated to supporting individuals with devastating diseases a... |
|
|
Invention
|
Cyclic cell penetrating peptides.
The present disclosure is directed to cell penetrating peptide... |
|
|
Invention
|
Ocular delivery of therapeutic agents. The present disclosure is directed to compounds and compos... |
|
|
Invention
|
Methods for the sequencing of phosphorodiamidate morpholino oligomers (pmo) and peptide-pmo (ppmo... |
|
|
Invention
|
Hybrid oligonucleotides |
|
|
Invention
|
Hybrid oligonucleotides. Provided herein are methods for making hybrid oligonucleotides, hybrid o... |
|
|
Invention
|
Compositions and methods for delivery of nucleic acid therapeutics. Provided herein are conjugate... |
|
|
Invention
|
Cyclic peptides for delivering therapeutics. La présente invention concerne la synthèse de peptid... |
|
|
Invention
|
Cyclic peptides for delivering therapeutics. The present disclosure relates to the synthesis of c... |
|
|
Invention
|
Β-catenin antibodies. β catenin antibodies or antigen binding fragments thereof are provided. The... |
|
2022
|
P/S
|
House mark for a line of pharmaceuticals, but not including pharmaceuticals intended to treat mul... |
|
|
Invention
|
Intracellular targeting of oligonucleotides. Compounds are provided include a cell penetrating pe... |
|
|
Invention
|
Compounds and methods for skipping exon 44 in duchenne muscular dystrophy.
Described herein in v... |
|
|
Invention
|
Compositions and methods for skipping exon 45 in duchenne muscular dystrophy.
Described herein i... |
|
|
Invention
|
Compounds and methods for skipping exon 44 in duchenne muscular dystrophy. Described herein in va... |
|
|
Invention
|
Compositions and methods for skipping exon 45 in duchenne muscular dystrophy. Described herein in... |
|
|
Invention
|
Antisense compounds and methods for targeting cug repeats. Compounds comprising a cyclic peptide,... |
|
|
Invention
|
Synthesis of fmoc-protected morpholino monomers and oligomers.
The present disclosure provides t... |
|
|
Invention
|
Compositions and methods for modulating mrna splicing.
Compounds include at least one cyclic cel... |
|
|
Invention
|
Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity.
Compoun... |
|
|
Invention
|
Compositions and methods for intracellular therapeutics.
Provided herein are compounds that incl... |
|
|
Invention
|
Compositions and methods for modulating gene expression.
Compounds that include a cyclic cell pe... |
|
|
Invention
|
Antigen-binding and antigen degradation constructs.
Degradation compounds include a cyclic cell ... |
|
|
Invention
|
Compositions and methods for intracellular therapeutics. Provided herein are compounds that inclu... |
|
|
Invention
|
Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity. Compound... |
|
|
Invention
|
Antigen-binding and antigen degradation constructs. Degradation compounds include a cyclic cell p... |
|
|
Invention
|
Compositions and methods for modulating gene expression. Compounds that include a cyclic cell pen... |
|
|
Invention
|
Compositions and methods for modulating tissue distribution of intracellular therapeutics. Provid... |
|
|
Invention
|
Compositions and methods for modulating mrna splicing. Compounds include at least one cyclic cell... |
|
|
Invention
|
Cyclic cell penetrating peptides. The present disclosure is directed to cell penetrating peptides... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of diseases a... |
|
|
P/S
|
Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceuticals for preventi... |
|
|
P/S
|
Pharmaceuticals for human use. Pharmaceutical research and development services. |
|
|
P/S
|
Pharmaceutical preparations for the treatment in humans of autoimmune diseases and disorders, gen... |
|
2021
|
Invention
|
Nucleases comprising cell penetrating peptide sequences. The present disclosure provides systems,... |
|
|
Invention
|
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy. Disclos... |
|
|
P/S
|
Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations ... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical preparations administered via parenteral in... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceuticals for
prevention and treatment of diseases ... |
|
2020
|
Invention
|
Compositions for delivery of antisense compounds.
Provided herein are compounds comprising cycli... |
|
|
Invention
|
Compositions for delivery of antisense compounds. Provided herein are compounds comprising cyclic... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, art... |
|
|
P/S
|
Pharmaceuticals; pharmaceuticals for human use. Pharmaceutical research and development services. |
|
|
P/S
|
House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuti... |
|
|
P/S
|
House mark for a full line of pharmaceuticals, but not including pharmaceuticals intended to trea... |
|
|
Invention
|
Cell penetrating peptides and methods of making and using thereof. Disclosed herein are compounds... |
|
2018
|
P/S
|
Pharmaceuticals; pharmaceuticals for human use, namely,
pharmaceuticals for prevention and treat... |
